SEC Company Response from CYTRX CORP (LADX) (CIK 0000799698) (LADX) — Jul 12, 2021

CYTRX CORP (LADX) (CIK 0000799698)
Date: July 12, 2021 · CIK: 0000799698 · Accession: 0001493152-21-016613

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-255431

Date

April 22, 2021

Author

Corporation

Form

CORRESP

Company

CYTRX CORP (LADX) (CIK 0000799698)

Letter

CytRx Corporation

11726 San Vicente Boulevard, Suite 650

Los Angeles, California 90049

July 12, 2021

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

Securities and Exchange Commission

Washington, D.C. 20549

Re: CytRx Corporation

Registration Statement on Form S-3, as amended

Filed on April 22, 2021

File No. 333-255431 (the “Registration Statement”)

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, CytRx Corporation (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement, as amended, so that it may become effective at 4:00 p.m., Eastern Time, on July 12, 2021, or as soon thereafter as practicable.

Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.

Very
truly yours,
CytRx
Corporation

Show Raw Text

CORRESP
1
filename1.htm

CytRx
Corporation

11726 San Vicente Boulevard, Suite 650

Los Angeles, California 90049

July
12, 2021

VIA
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

Office
of Life Sciences

Securities
and Exchange Commission

Washington,
D.C. 20549

    Re:
    CytRx
    Corporation

Registration
Statement on Form S-3, as amended

Filed
on April 22, 2021

File
No. 333-255431 (the “Registration Statement”)

Request
for Acceleration

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under
the Securities Act of 1933, as amended, CytRx Corporation (the “Company”) hereby respectfully requests acceleration
of the effective date of the Registration Statement, as amended, so that it may become effective at 4:00 p.m., Eastern Time, on July
12, 2021, or as soon thereafter as practicable.

Should
any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes
and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.

    Very
    truly yours,

    CytRx
    Corporation

    By:

    /s/
    Steven A. Kriegsman

    Steven
    A. Kriegsman

    Chairman
    and Chief Executive Officer

    cc:
    Rick
    A. Werner, Esq., Haynes and Boone, LLP

SecProbe.io